全文获取类型
收费全文 | 9883篇 |
免费 | 791篇 |
国内免费 | 2篇 |
专业分类
10676篇 |
出版年
2023年 | 49篇 |
2022年 | 98篇 |
2021年 | 162篇 |
2020年 | 93篇 |
2019年 | 132篇 |
2018年 | 167篇 |
2017年 | 154篇 |
2016年 | 269篇 |
2015年 | 452篇 |
2014年 | 511篇 |
2013年 | 567篇 |
2012年 | 830篇 |
2011年 | 783篇 |
2010年 | 515篇 |
2009年 | 458篇 |
2008年 | 687篇 |
2007年 | 585篇 |
2006年 | 554篇 |
2005年 | 448篇 |
2004年 | 467篇 |
2003年 | 453篇 |
2002年 | 402篇 |
2001年 | 120篇 |
2000年 | 126篇 |
1999年 | 127篇 |
1998年 | 99篇 |
1997年 | 77篇 |
1996年 | 73篇 |
1995年 | 57篇 |
1994年 | 55篇 |
1993年 | 64篇 |
1992年 | 83篇 |
1991年 | 54篇 |
1990年 | 49篇 |
1989年 | 58篇 |
1988年 | 51篇 |
1987年 | 50篇 |
1986年 | 50篇 |
1985年 | 46篇 |
1984年 | 36篇 |
1983年 | 55篇 |
1982年 | 25篇 |
1981年 | 33篇 |
1980年 | 36篇 |
1979年 | 37篇 |
1978年 | 24篇 |
1977年 | 27篇 |
1976年 | 27篇 |
1975年 | 23篇 |
1974年 | 39篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
Based on its proven anabolic effects on bone in osteoporosis patients, recombinant parathyroid hormone (PTH1-34) has been evaluated as a potential therapy for skeletal repair. In animals, the effect of PTH1-34 has been investigated in various skeletal repair models such as fractures, allografting, spinal arthrodesis and distraction
osteogenesis. These studies have demonstrated that intermittent PTH1-34 treatment enhances and accelerates the skeletal repair process via a number of mechanisms, which include effects on mesenchymal
stem cells, angiogenesis, chondrogenesis, bone formation and resorption. Furthermore, PTH1-34 has been shown to enhance bone repair in challenged animal models of aging, inflammatory arthritis and glucocorticoid-induced
bone loss. This pre-clinical success has led to off-label clinical use and a number of case reports documenting PTH1-34 treatment of delayed-unions and non-unions have been published. Although a recently completed phase 2 clinical trial of PTH1-34 treatment of patients with radius fracture has failed to achieve its primary outcome, largely because of effective healing
in the placebo group, several secondary outcomes are statistically significant, highlighting important issues concerning the
appropriate patient population for PTH1-34 therapy in skeletal repair. Here, we review our current knowledge of the effects of PTH1-34 therapy for bone healing, enumerate several critical unresolved issues (e.g., appropriate dosing regimen and indications)
and discuss the long-term potential of this drug as an adjuvant for endogenous tissue engineering. 相似文献
2.
Proteins in the molecular weight range of 10 000–170 000 were separated by high performance gel permeation chromatography. Silica particles with 30 nm or 50 nm pores were derivatized with glycidoxy-propyltrimethoxysilane and used as support. The proteins were eluted with 50% formic acid. A protein fraction which induces endodermal and mesodermal tissues in amphibian gastrula ectoderm was purified by this method. 相似文献
3.
Amélie Faubert Angela Samaan Jacques Thibodeau 《The Journal of biological chemistry》2002,277(4):2750-2755
In the endocytic pathway of antigen-presenting cells, HLA-DM catalyzes the exchange between class II-associated invariant chain peptide (CLIP) and antigenic peptides onto major histocompatibility complex class II molecules. At low pH of lysosomal compartments, both HLA-DM and HLA-DR undergo conformational changes, and it was recently postulated that two partially exposed tryptophans on HLA-DM might be involved in the interaction between the two molecules. To define contact regions on HLA-DM, we have conducted site-directed mutagenesis on those two hydrophobic residues. The HLA-DM alphaW62A,betaW120A (DM(W62A/W120A)) double mutant was expressed in HLA-DR(+) HeLa cells expressing invariant chain, and the activity of this DM molecule was assessed. Flow cytometry analysis of cell surface DR-CLIP complexes revealed that DM(W62A/W120A) removes CLIP as efficiently as its wild-type counterpart. DM(W62A/W120A) was found in the endocytic pathway by immunofluorescence, and DM-DR complexes were immunoprecipitated from these cells at pH 5. Finally, mutations alphaW62A and betaW120A on HLA-DM did not affect the association with HLA-DO. The complex egresses the endoplasmic reticulum and accumulates in endocytic vesicles. Moreover, DO and DM(W62A/)W120A were co-immunoprecipitated at pH 7. We conclude that the alpha62 and beta120 tryptophan residues are not required for the activity of DM, nor are they directly implicated in the interaction with DR or DO. 相似文献
4.
5.
6.
Summary A male fetus of a pregnancy known to be at risk for X-linked mental retardation with fragile site Xq27 was found to be affected by demonstrating the marker X-chromosome in five of 180 (2.8%) of metaphases derived from amniocytes cultured in medium 199. The results were confirmed in fetal lymphocytes (25 of 86 metaphases, i.e. 29%), and fetal fibroblasts (five of 100 metaphases when cultured in medium 199, and 14 of 100 after exposure to methotrexate for 43 h).This work was supported in part by a research grant from the Deutsche Forschungsgemeinschaft 相似文献
7.
8.
9.
10.
Molecular mechanisms of ceramide-mediated CD95 clustering. 总被引:2,自引:0,他引:2
H Grassmé H Schwarz E Gulbins 《Biochemical and biophysical research communications》2001,284(4):1016-1030
Receptor clustering has been suggested as a crucial mechanism to initiate receptor signaling. Here we show that ceramide in sphingolipid-rich membrane rafts mediates clustering of CD95. Neutralization of surface ceramide or inhibition of its endogenous generation prevented CD95 clustering. Furthermore, application of ceramide at the cell surface triggered clustering of active but not inactive CD95. Apoptosis was inhibited by neutralization of surface ceramide or inhibition of ceramide release in vitro and in vivo. Thus, we conclude that surface ceramide mediates CD95 clustering, which is required for initiation of apoptosis, at least in some cell types. 相似文献